Invention Grant
- Patent Title: Anti-EFNA4 antibody-drug conjugates
- Patent Title (中): 抗EFNA4抗体 - 药物共轭物
-
Application No.: US14525442Application Date: 2014-10-28
-
Publication No.: US09381205B2Publication Date: 2016-07-05
- Inventor: Marc Isaac Damelin , Kiran Manohar Khandke , Puja Sapra , Alexander John Bankovich , Scott J. Dylla
- Applicant: Pfizer, Inc. , Stem CentRx, Inc.
- Applicant Address: US NY New York US CA South San Francisco
- Assignee: Pfizer, Inc.,Stemcentrx, Inc.
- Current Assignee: Pfizer, Inc.,Stemcentrx, Inc.
- Current Assignee Address: US NY New York US CA South San Francisco
- Agency: Womble Carlyle Sandridge & Rice, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/704 ; A61K47/48 ; C07K16/30
Abstract:
The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
Public/Granted literature
- US20150125472A1 ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES Public/Granted day:2015-05-07
Information query
